AsiaBusiness Marketmind: Banks lob earnings into giddy markets The Cheap InvestorJuly 14, 2023July 14, 20230 A look at the day ahead in U.S. and global markets from Mike Dolan Flush with hope that impressive disinflation…
BusinessEconomy India’s June trade deficit in line with expectations The Cheap InvestorJuly 14, 2023July 14, 20230 By Shivangi Acharya and Riddhima Talwani NEW DELHI (Reuters) -India’s merchandise trade deficit in June was in line with expectations…
BusinessEconomy Euro zone almost eliminates trade deficit in May The Cheap InvestorJuly 14, 2023July 14, 20230 BRUSSELS (Reuters) – The euro zone almost eliminated its trade deficit in May, non-adjusted data showed on Friday, as exports…
AsiaAustralia Australia picks first female central bank head to shepherd through reform The Cheap InvestorJuly 14, 2023July 14, 20230 By Wayne Cole SYDNEY (Reuters) – Australia has appointed the first female head of its central bank, passing over the…
BusinessEconomy A look at the state of US bank credit as earnings season begins The Cheap InvestorJuly 14, 2023July 14, 20230 By Safiyah Riddle (Reuters) – Friday kicks off a week or more of earnings reports from U.S. banks covering the…
BusinessEconomy US court refuses FTC request to pause Microsoft deal for Activision The Cheap InvestorJuly 14, 2023July 14, 20230 WASHINGTON (Reuters) – A U.S. federal court rejected the Federal Trade Commission’s request that it order Microsoft to temporarily hold…
BusinessEconomy US asks appeals court to pause Microsoft deal after lower court refuses The Cheap InvestorJuly 14, 2023July 14, 20230 By Diane Bartz and David Shepardson WASHINGTON (Reuters) -The U.S. Federal Trade Commission on Thursday asked an appeals court to…
BusinessEconomy Small business distress index hits mid-2020 high The Cheap InvestorJuly 14, 2023July 14, 20230 (This July 13 story has been corrected to say Gotshal, not Gotschal, in paragraph 1) By Chiara Elisei LONDON (Reuters)…
BusinessEurope Roivant in talks to sell bowel disease drug to Roche in over $7 billion deal – WSJ The Cheap InvestorJuly 14, 2023July 14, 20230 (Reuters) -Biotech company Roivant Sciences is in talks to sell an experimental drug to treat inflammatory bowel diseases, including ulcerative…
AsiaAustralia Australia No.3 bank clinches union deal for staff to work from home The Cheap InvestorJuly 14, 2023July 14, 20230 By Byron Kaye SYDNEY (Reuters) – National Australia Bank (NAB), the No.3 lender, reached a deal that lets employees work…